{
  "actions": [
    {
      "acted_at": "2003-04-11",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2003-04-11",
      "action_code": "",
      "committees": [
        "SSFI"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Finance.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s891-108",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "Senate Finance",
      "committee_id": "SSFI"
    }
  ],
  "congress": "108",
  "cosponsors": [],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2003-04-11",
  "number": "891",
  "official_title": "A bill to provide substantial reductions in the price of prescription drugs for medicare beneficiaries.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Prescription Drug Equity for Seniors Act of 2003",
  "sponsor": {
    "bioguide_id": "J000177",
    "district": null,
    "name": "Johnson, Tim",
    "state": "SD",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2003-04-11",
  "subjects": [
    "Ambulatory care",
    "Commerce",
    "Congress",
    "Congressional reporting requirements",
    "Drug industry",
    "Drugs",
    "Governmental investigations",
    "Health",
    "Life expectancy",
    "Medicare",
    "Pharmacies",
    "Prescription pricing",
    "Price discrimination",
    "Social Welfare",
    "Terminal care",
    "Terminally ill"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in Senate",
    "asOf": "2003-04-11",
    "date": "2006-11-28T17:35:40Z",
    "text": "Prescription Drug Fairness for Seniors Act of 2003 - Requires each participating manufacturer of a covered outpatient drug to make it available for purchase by each pharmacy: (1) in an amount equal to the aggregate amount of the drug sold or distributed by the pharmacy to Medicare beneficiaries; and (2) at a price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug. Sets forth special provisions with respect to hospice programs."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Prescription Drug Equity for Seniors Act of 2003",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to provide substantial reductions in the price of prescription drugs for medicare beneficiaries.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Prescription Drug Equity for Seniors Act of 2003",
      "type": "short"
    }
  ],
  "updated_at": "2023-01-15T23:33:09Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/108/s/BILLSTATUS-108s891.xml"
}